Armistice Capital’s ENvue Medical Inc FEED Stock Holding History

Armistice Capital’s Portfolio FEED Stock Details FEED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,721	Closed	-$112K	–	270
2024 Q4	$112K	Sell	1,721 -813	-32%	-$54.8K	﹤0.01%	202
2024 Q3	$171K	Buy	2,534 +1,290	+104%	+$93.8K	﹤0.01%	224
2024 Q2	$95.8K	Sell	1,244 -1,037	-45%	-$88.3K	﹤0.01%	227
2024 Q1	$226K	Buy	+2,281	New	+$247K	﹤0.01%	261
2023 Q4	–	Sell	-264	Closed	-$57.2K	–	340
2023 Q3	$57.2K	Buy	+264	New	+$78.6K	﹤0.01%	225

Other funds holding FEED

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Armistice Capital's FEED Position: Q1 2025 in Review

Armistice Capital sold out of ENvue Medical Inc (FEED) in Q1 2025, closing a stake of 1,721 shares — an estimated $112K sold.

Armistice Capital first reported a position in FEED in Q3 2023 and held it in 5 quarters. The position peaked at $226K in Q1 2024. 4 funds tracked by Wall St. Rank hold FEED as of Q1 2025.

Armistice Capital reported no remaining ENvue Medical Inc position as of Q1 2025 after selling out during the quarter.
Armistice Capital sold 1,721 ENvue Medical Inc shares in Q1 2025, an estimated $112K.
Armistice Capital first reported a position in ENvue Medical Inc in Q3 2023 and held it in 5 quarters.
Armistice Capital's ENvue Medical Inc position peaked at $226K in Q1 2024.
4 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.